SEBIA SINGAPORE PTE. LTD.
Last Updated: 13 Apr 2026
At Sebia, our mission is to revolutionize the field of in vitro diagnostics by developing cutting-edge technologies that enable healthcare professionals to better understand and diagnose chronic and metabolic diseases. By leveraging our expertise in capillary electrophoresis (CE) and protein analysis, we aim to create a new language of life that facilitates the detection, monitoring, and treatment of diseases such as cancer, obesity, aging, and depression. With a focus on scientific excellence and innovation, we strive to improve patient outcomes and quality of life.
Country of registration | Singapore |
Registration number | 201925060K |
Local SIC | |
Incorporation date | 1 Aug 2019 |
Company age | 6 years 10 months |
Official entity type | Private Limited Company |
No. of officers | 11 |
Contact
Address:
51 CHANGI BUSINESS PARK CENTRAL 2, #09-12, THE SIGNATURE, Singapore 486066
Access Key Decision Makers
This is the legal entity page of SEBIA SINGAPORE PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (2)
- SEBIAView MoreFranceAt Sebia, our mission is to revolutionize the field of in vitro diagnostics by developing cutting-edge technologies that enable healthcare professionals to better understand and diagnose chronic and metabolic diseases. By leveraging our expertise in capillary electrophoresis (CE) and protein analysis, we aim to create a new language of life that facilitates the detection, monitoring, and treatment of diseases such as cancer, obesity, aging, and depression. With a focus on scientific excellence and innovation, we strive to improve patient outcomes and quality of life.
- SEBIA SEA & APAC EXPORTView MoreSingaporeSebia is the global leader in cutting-edge clinical protein electrophoresis technology for in-vitro diagnostic (IVD) testing. Our protein analysis systems enable the screening and monitoring of various diseases and conditions, including oncology (Multiple Myeloma), metabolic disorders (Diabetes), and Hemoglobinopathy and rare pathologies.
This is the legal entity page of SEBIA SINGAPORE PTE. LTD.. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Fiscal/Budgeting Period | October - December |
Auditor | WENSEN CORPORATE ASSURANCE |
Revenue | 1m - 5m |
Financial period end date | 31 Dec 2021 |
Share Capital - Ordinary shares | SGD 600,000 |
Last updated: 13 Apr 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of SEBIA SINGAPORE PTE. LTD.?
- Where is SEBIA SINGAPORE PTE. LTD.'s headquarter?
- What is SEBIA SINGAPORE PTE. LTD.'s contact number?
- What SEBIA SINGAPORE PTE. LTD.'s spending power?
- Does SEBIA SINGAPORE PTE. LTD. have a presence in the domain it operates in?